Evidence map›Paper›PMID 37344042›Full record

Observational studyJournal of the American College of Cardiology2023

Thrombus Burden and Outcomes in Patients With COVID-19 Presenting With STEMI Across the Pandemic.

Krishnaraj S Rathod, Zhi Teoh, Angelos Tyrlis, Fizzah A Choudry, Stephen M Hamshere, Katrina Comer, Oliver Guttmann, Ajay K Jain, Muhiddin A Ozkor, Andrew Wragg and 4 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of the American College of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past.Journal of the American College of Cardiology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Krishnaraj S RathodDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Zhi TeohDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Angelos TyrlisDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Fizzah A ChoudryDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Stephen M HamshereDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Katrina ComerDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Oliver GuttmannDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Ajay K JainDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Muhiddin A OzkorDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Andrew WraggDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
R Andrew ArchboldDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.
Andreas BaumbachDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Anthony MathurDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Daniel A JonesDepartment of Cardiology, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom. Electronic address: dan.jones8@nhs.net.
St Bartholomew's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been previously reported during the first COVID-19 outbreak that patients presenting with ST-segment elevation myocardial infarction (STEMI) and concurrent COVID-19 infection have increased thrombus burden and poorer outcomes. To date, there have been no reports comparing the outcomes of COVID-19-positive STEMI patients across all waves of the pandemic.

objectivesThis study compared the baseline demographic, procedural, and angiographic characteristics alongside the clinical outcomes of patients presenting with STEMI and concurrent COVID-19 infection across the COVID-19 pandemic in the United Kingdom.

methodsThis was a single-center, observational study of 1,269 consecutive patients admitted with confirmed STEMI treated with percutaneous coronary intervention (between January 3, 2020 and October 3, 2022). COVID-19-positive patients were split into 3 groups based upon the time course of the pandemic, and a comparison was made between waves.

resultsA total of 154 COVID-19-positive patients with STEMI were included in the present analysis and were compared with 1,115 COVID-19-negative patients. Early during the pandemic (wave 1), STEMI patients presenting with concurrent COVID-19 infection had high rates of cardiac arrest, evidence of increased thrombus burden, bigger infarcts, and worse outcomes. However, by wave 3, no differences existed in outcomes between COVID-19-positive and -negative patients, with significant differences compared with earlier COVID-19-positive patients. Poor outcomes later in the study period were predominantly in unvaccinated individuals.

conclusionsSignificant changes have occurred in the clinical characteristics, angiographic features, and outcomes of STEMI patients with COVID-19 infection treated by primary percutaneous coronary intervention during the course of the pandemic. Importantly, outcomes of recent waves and in vaccinated individuals are no different to a non-COVID-19 population.

Indexed as

COVID-19Percutaneous Coronary InterventionST Elevation Myocardial InfarctionThrombosisHumansPandemicsTreatment OutcomeUnited KingdomCOVID-19ECGPCISTEMI

Identifiers

PMID37344042
PMCPMC10278669
OpenAlexW4381194313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.